NCT05765487View on ClinicalTrials.gov

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

January 26, 2024

Study Completion Date

October 21, 2024

Conditions
Sexual Arousal Disorder
Interventions
DRUG

Sildenafil

Sildenafil Cream, 3.6%

DRUG

Vehicle

No Active or experimental ingredients

DRUG

Placebo

Cream with only L-arginine

Trial Locations (1)

Unknown

Pharma Medica Research, Inc., Mississauga

Sponsors
All Listed Sponsors
collaborator

Strategic Science & Technologies, LLC

INDUSTRY

lead

Daré Bioscience, Inc.

INDUSTRY